|
MPS 2
MCID: MCP009
|
Mucopolysaccharidosis Ii malady |
|
Sources: 30NIH Rare Diseases, 17Genetics Home Reference, 44Wikipedia, 33OMIM, 15GeneReviews, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Mucopolysaccharidosis II (MPS II), also commonly known as Hunter syndrome, is a condition that occurs almost exclusively in males. Affected individuals typically have distinctive facial features, a large head, hydrocephalus, an enlarged liver and spleen, umbilical or inguinal hernia, and hearing loss. Individuals with this condition may have joint deformities and heart valve problems. MPS II is caused by mutations in the IDS gene. There are two types of MPS II, called the severe and attenuated types. While both types affect many different parts of the body, people with the severe type also experience a decline in intellectual function and a more rapid disease progression. The life expectancy for people with the severe type is 10 to 20 years. Individuals with the attenuated type typically live into adulthood and their intelligence is not affected. Heart disease and airway obstruction are major causes of death in people with both types of MPS II.30
MalaCards: Mucopolysaccharidosis Ii, also known as mucopolysaccharidosis type ii, is related to mucopolysaccharidosis and lysosomal storage disease. An important gene associated with Mucopolysaccharidosis Ii is IDS (iduronate 2-sulfatase), and among its related pathways are Lysosome and Glycosaminoglycan degradation. The compound heparan sulfate have been mentioned in the context of this disorder. Affiliated tissues include spleen, heart and liver. Genetics Home Reference: Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a condition that affects many different parts of the body and occurs almost exclusively in males. It is a progressively debilitating disorder; however, the rate of progression varies among affected individuals.17 Wikipedia: Hunter syndrome, or mucopolysaccharidosis Type II, is a lysosomal storage disease caused by a deficient...44 more... OMIM: 309900 GeneReviews summary for hunter |
|
Sources: 6Disease Ontology, 7diseasecard, 33OMIM, 8DISEASES, 43UMLS, 15GeneReviews, 30NIH Rare Diseases, 16GeneTests, 17Genetics Home Reference, 32Novoseek , 40SNOMED-CT, 27NCIt, 24MeSH See all sources |
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 309900
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 21LifeMap Discovery™, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for mucopolysaccharidosis ii Drug clinical trials:Search ClinicalTrials for mucopolysaccharidosis ii Search NIH Clinical Center for mucopolysaccharidosis ii Search CenterWatch for mucopolysaccharidosis ii Cell-based therapeutics:![]() The database of embryonic development, stem cell research and regenerative medicine Stem-Cell-Based therapeutic approaches for mucopolysaccharidosis ii:
|
|
Sources: 16GeneTests See all sources |
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to mucopolysaccharidosis ii:22Spleen, Heart, Liver
|
|
|
|
Sources: 35PubMed See all sources |
Articles related to mucopolysaccharidosis ii:
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 20KEGG See all sources |
|
Sources: 32Novoseek , 18HMDB See all sources |
|
Sources: 12Gene Ontology See all sources |

